Company Of The Day: Johnson & Johnson

by Trefis Team
+21.65%
Upside
165
Market
200
Trefis
JNJ
Johnson & Johnson
Rate   |   votes   |   Share

What?

Countries in the European Union placed an order for approximately 37 million Covid-19 vaccine doses from Johnson & Johnson (NYSE:J&J), adding to the E.U’s initial order of 200 million doses.

So What?

While the bloc had the option to buy an additional 100 million doses, the current orders are just about a third of that number. Countries are likely reluctant to double down on the shot, as J&J has faced significant production problems, shipping just about 15 million doses to the E.U. in Q2, well below an anticipated 55 million.

See Our Complete Analysis For Johnson & Johnson

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market since 2016

See all Trefis Price Estimates and Download Trefis Data here

What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams

Rate   |   votes   |   Share

Comments

Name (Required)
Email (Required, but never displayed)
Be the first to comment!